Percutaneous pulmonary valve implantation in a dysfunctional Trifecta® bioprothesis after high-pressure balloon fracturing.
Florian LanghammerAnja LehnerNikolaus A HaasAndré JakobPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
A percutaneous pulmonary valve-in-valve (PPVIV) implantation in small surgical tissue valves may be limited due to the valve's initial diameter. Fracturing of the valve's integrity by high-pressure balloons may enhance the diameter and facilitate subsequent PPVIV with a large valve. To the best of our knowledge, the Trifecta® valve seemed not to be accessible for fracturing. We report a case of successful 19-mm Trifecta valve fracturing, followed by PPVIV using a 26-mm Edwards SAPIEN 3 valve in pulmonary position. By repetitively using a high-pressure balloon 5 mm larger than the labeled valve size, we were able to fracture the valve's integrity and implant a 26-mm valve thereafter. Therefore, Trifecta valve appears to be suitable for valve ring fracturing and subsequent PPVIV in certain patients.
Keyphrases
- aortic valve
- mitral valve
- aortic stenosis
- transcatheter aortic valve replacement
- ejection fraction
- transcatheter aortic valve implantation
- aortic valve replacement
- end stage renal disease
- healthcare
- heart failure
- computed tomography
- chronic kidney disease
- atrial fibrillation
- peritoneal dialysis
- pet ct
- optical coherence tomography